Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ASMB

Assembly Biosciences, Inc.

Healthcare · USD

Set alert

Price alert · ASMB

All alert types
20.13 USD -0.73 -3.50%
As of Oct 30, 2026 Extended hours 20.13 0.00%
Bid
20.15 × 2
Ask
20.19 × 2
19.98 Day range 21.00
19.67 52-week range 38.50
YTD
-40.81%
1 year
-33.17%
Open
20.86
Prev close
20.86
Mkt cap
409.86M
Vol
136.87K
Avg vol
291.99K
EPS
1.04
P/E
19.36
Div yield
0.00%
More statistics
Low
19.98
High
21.00
Forward P/E
-2.12
Beta
0.59
Short ratio
0.41
Inst. own
18.79%
Dividend
0.00
Ex-div date
Earnings
Mar 27, 2024
50-d avg
16.31
200-d avg
15.02
1y target
35.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ASMB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

7.52 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -61.8×
FY 2016: -5.7×FY 2017: -22.5×FY 2018: -6.8×FY 2019: -8.8×FY 2020: -4.8×FY 2021: -0.8×FY 2022: -0.7×FY 2023: -0.7×FY 2024: -2.4×FY 2025: -61.8×
FY 2016 5y median -0.8× FY 2025
P/S 5.3×
FY 2016: 0.0×FY 2017: 107×FY 2018: 41.8×FY 2019: 54.0×FY 2020: 3.6×FY 2021: 16.1×FY 2022: 0.0×FY 2023: 6.3×FY 2024: 3.3×FY 2025: 5.3×
FY 2016 5y median 5.3× FY 2025
P/B 1.8×
FY 2016: 3.1×FY 2017: 8.5×FY 2018: 2.9×FY 2019: 3.2×FY 2020: 1.2×FY 2021: 0.6×FY 2022: 0.8×FY 2023: 1.1×FY 2024: 2.8×FY 2025: 1.8×
FY 2016 5y median 1.1× FY 2025
P/FCF -9.3×
FY 2016: -7.2×FY 2017: 968×FY 2018: -9.5×FY 2019: -10.1×FY 2020: -4.4×FY 2021: -1.0×FY 2022: -0.7×FY 2023: 2.0×FY 2024: -1.9×FY 2025: -9.3×
FY 2016 5y median -1.0× FY 2025
EV/EBITDA -54.3×
FY 2016: -5.0×FY 2017: -17.0×FY 2018: -6.2×FY 2019: -8.0×FY 2020: -4.1×FY 2021: -0.7×FY 2022: -0.2×FY 2023: -0.5×FY 2024: -1.5×FY 2025: -54.3×
FY 2016 5y median -0.7× FY 2025
EV/Sales 4.5×
FY 2016: 0.0×FY 2017: 97.8×FY 2018: 39.0×FY 2019: 51.8×FY 2020: 3.0×FY 2021: 9.9×FY 2022: 0.0×FY 2023: 3.8×FY 2024: 2.1×FY 2025: 4.5×
FY 2016 5y median 3.8× FY 2025
FCF Yield -10.8%
FY 2016: -13.9%FY 2017: 0.1%FY 2018: -10.6%FY 2019: -9.9%FY 2020: -22.6%FY 2021: -95.7%FY 2022: -134.4%FY 2023: 49.9%FY 2024: -54.0%FY 2025: -10.8%
FY 2016 5y median -54.0% FY 2025

Profitability

Gross Margin 99.8%
FY 2016: 0.0%FY 2017: -390.4%FY 2018: -391.4%FY 2019: -434.5%FY 2020: -28.1%FY 2021: 100.0%FY 2022: 0.0%FY 2023: -582.7%FY 2024: -96.1%FY 2025: 99.8%
FY 2016 5y median 0.0% FY 2025
Operating Margin -16.8%
FY 2016: 0.0%FY 2017: -579.1%FY 2018: -626.4%FY 2019: -643.4%FY 2020: -81.9%FY 2021: -2121.7%FY 2022: 0.0%FY 2023: -902.5%FY 2024: -159.3%FY 2025: -16.8%
FY 2016 5y median -159.3% FY 2025
Net Margin -8.5%
FY 2016: 0.0%FY 2017: -474.7%FY 2018: -613.0%FY 2019: -611.6%FY 2020: -78.6%FY 2021: -2076.4%FY 2022: 0.0%FY 2023: -854.8%FY 2024: -140.9%FY 2025: -8.5%
FY 2016 5y median -140.9% FY 2025
ROE -3.0%
FY 2016: -55.4%FY 2017: -37.8%FY 2018: -43.1%FY 2019: -35.7%FY 2020: -25.8%FY 2021: -76.9%FY 2022: -112.6%FY 2023: -149.0%FY 2024: -120.4%FY 2025: -3.0%
FY 2016 5y median -112.6% FY 2025
ROIC -5.8%
FY 2016: -49.1%FY 2017: -27.7%FY 2018: -37.2%FY 2019: -31.4%FY 2020: -24.7%FY 2021: -73.1%FY 2022: -105.9%FY 2023: -65.4%FY 2024: -63.2%FY 2025: -5.8%
FY 2016 5y median -65.4% FY 2025
ROA -2.4%
FY 2016: -45.1%FY 2017: -25.3%FY 2018: -33.9%FY 2019: -28.1%FY 2020: -21.9%FY 2021: -68.0%FY 2022: -91.5%FY 2023: -44.7%FY 2024: -33.7%FY 2025: -2.4%
FY 2016 5y median -44.7% FY 2025

Growth (YoY)

Revenue 153.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 64.1%FY 2019: 7.8%FY 2020: 395.6%FY 2021: -92.1%FY 2022: -100.0%FY 2023: 0.0%FY 2024: 298.2%FY 2025: 153.5%
FY 2016 FY 2025
Operating Income 73.3%
FY 2016: -52.7%FY 2017: -15.3%FY 2018: -77.6%FY 2019: -10.8%FY 2020: 36.9%FY 2021: -104.8%FY 2022: 29.1%FY 2023: 31.3%FY 2024: 29.7%FY 2025: 73.3%
FY 2016 FY 2025
EPS (diluted) 91.8%
FY 2016: -42.0%FY 2017: 6.2%FY 2018: -65.1%FY 2019: 30.2%FY 2020: 46.0%FY 2021: -140.0%FY 2022: 36.6%FY 2023: 41.4%FY 2024: 50.0%FY 2025: 91.8%
FY 2016 FY 2025
Free Cash Flow 19.5%
FY 2016: -86.8%FY 2017: 102.8%FY 2018: -6659.2%FY 2019: -31.1%FY 2020: 23.9%FY 2021: -48.0%FY 2022: 12.4%FY 2023: 126.6%FY 2024: -327.4%FY 2025: 19.5%
FY 2016 FY 2025

Financial Health

Current Ratio 5.2×
FY 2016: 7.5×FY 2017: 9.1×FY 2018: 12.0×FY 2019: 11.6×FY 2020: 9.2×FY 2021: 9.6×FY 2022: 6.0×FY 2023: 3.4×FY 2024: 2.4×FY 2025: 5.2×
FY 2016 5y median 5.2× FY 2025
Quick Ratio 5.2×
FY 2016: 7.5×FY 2017: 9.1×FY 2018: 12.0×FY 2019: 11.6×FY 2020: 9.2×FY 2021: 9.6×FY 2022: 6.0×FY 2023: 3.5×FY 2024: 2.4×FY 2025: 5.2×
FY 2016 5y median 5.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 9.3×
FY 2016: 0.6×FY 2017: 1.6×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.8×FY 2021: 0.4×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.9×FY 2025: 9.3×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31